Ansell Limited (ANN)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!

General Information
Company Name: Ansell Limited
Stock Code: ANN
GICS Sub-Industry: Health Care Supplies
Market Cap ($M): 3,066
Equiv. Shares (M): 153

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 20.020 $ 20.090 $ 20.220 $ 19.980 $ 20.320 427,225 $ -0.300  -1.476 %

Current Broker Consensus Recommendation more
Recommendation: Sell (3.6667)
Recommendation Date: 12th Nov 2014
Brokers Surveyed: 3

Company Overview

Business Description:
Ansell Limited (ANN) is a global provider of health and safety protection solutions. ANN designs, develops, manufactures and distributes a range of surgical, examination, industrial and household gloves, protective clothing and condoms. Currently, ANN operates four main business divisions which are medical, industrial, single use and sexual wellness.

Strategy Analysis:
ANN is focused on developing new and innovative products, new distribution channels and growing market share. Cost cutting, manufacturing rationalisations, and shifting its portfolio of products towards higher margin items aim to offset input cost pressures. ANN is shifting away from producing commoditised products with no pricing power to producing patentable products which avoid the commodity trap. Revenue growth is typically modest, in response ANN looks for new emerging markets, such as China and Eastern Europe for sales. ANN is also mindful of the necessity to invest in research and development in order to develop more patentable products, such as the highly successful Hyflex range. Ansell reported NPAT down 15.3% to $55.0m for the half-year ended 31 December 2012. Revenues from ordinary activities were $627.9m, up 5.1% from the same period last year. Diluted EPS was 41.8 cents compared to 49.2 cents last year. The net operating cash inflow was $44.8m compared to an outflow of $16.7m in the pcp. The interim dividend declared was 16 cents compared with 15 cents last year.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2016  F 244.1 159.7 21.3 12.5 55.6 2.8 0.0
2015  F 201.2 131.6 20.5 15.2 48.9 2.4 0.0
2014  A 156.9 109.2 2.9 17.7 39.0 2.0 0.0
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F
Ansell (ANN) $3,112 M 0.1120 0.1367 0.1265 17.5354 15.4267 13.6946 2.04 2.38 2.69

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
ANN 0.61 16.4 2.56 1.25 1.70
Market 0.92 15.1 1.19 1.73 1.50
Sector 0.65 18.0 2.36 1.60 2.14

Name Position Start Date
Mr Magnus Ranae Nicolin Chief Executive Officer,Managing Director 01 March 2010
Mr Peter Leslie Barnes Non-Executive Chairman 26 October 2001
Mr William Peter Day Non-Executive Director 20 August 2007
Mr Ronald J Bell Non-Executive Director 09 August 2005
Mr L (Dale) Crandall Non-Executive Director 11 October 2002
Ms Marissa T Peterson Non-Executive Director 22 August 2006
Mr John Andrew Bevan Non-Executive Director 01 August 2012
Mrs Annie Lo Non-Executive Director 01 January 2013
Mr Glenn Lawrence Lord Barnes Non-Executive Director,Non-Executive Chairman 12 September 2005

Name Position
Alistair Grant Associate General Counsel Asia Pacific,Company Secretary
Peter Dobbelsteijn Chief Commercial Officer EMEA and APAC region and Ansell Global Guardian
Mike Mattos Chief Commercial Officer North America region
Scott R Corriveau President Industrial GBU
Anthony Lopez President Medical GBU and Chief Commercial Officer LAC region
Joe Kubicek President Single Use GBU
Neil Salmon Senior Vice President and Chief Financial Offer
Steve Genzer Senior Vice President Global Supply Chain Operations
William Reilly Senior Vice President, Corporate General Counsel,Company Secretary

Substantial Shareholders
Holding Name
9,340,208 (7.15%) FMR LLC and FIL (formerly FMR Corp and FIL)
23,973,737 (18.01%) M&G Group
12,929,626 (9.89%) Lazard Asset Management Pacific Co
9,450,104 (7.23%) Matthews International Capital Management LLC

Calendar of Events
Date Event
11 September 2015 Report (Annual)
17 August 2015 Report (Prelim)
16 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Trading Forex

An educational booklet with information on becoming a successful trader, including essentials you need to learn and the skills you need to develop.

More details...


Australian Share Market - Close Up

CMC Markets 11/11/2014 | The Australian share market is in a decision zone - and trading from here may set the direction for the rest of the year.

Prices slashed - everything must go!

Nick Swales, Regional Director, Newcastle Office, Rathbones 27/10/2014 | “If you want to have a better performance than the crowd, you must do things differently from the crowd.” Sir John Templeton.

Aussie share market bulls now have company

Ric Spooner (Chief Market Analyst, CMC Markets) 20/10/2014 | Today, Australian investors will not have to go it alone buying stocks as they did for much of last week. Bargain hunters this morning will be supported by the morale boosting encouragement of a 3% turnaround in the German Dax and a 264 point rally in the Dow Jones.

The Importance of Ignoring the Noise of the Market

Carl Richards, director of investor education at the BAM Alliance 17/10/2014 | “As odd as it may sound, the sooner you start treating your investments like you treat life, the happier you’ll be with the outcome.”

You only dance twice

William H. Gross, Janus Capital Group 16/10/2014 | “Financial markets are artificially priced. In the bond market, there is nothing normal about a three year German Bund yielding “minus” 10 basis points.”

The Big Picture - Australia 200 Index

CMC Markets 8/10/2014 | Share market indices around the globe are breaking down. While analysts cast around for reasons, it’s clear that a time factor is in play. Simply put, many investors “feel” a correction is overdue. How low could it go?


Sponsored Links